Clinical studies recruiting near Chichester

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
Phase N/A · Nuvance Health · NCT04406831 A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Phase 2 · Fore Biotherapeutics · NCT05503797 Intensive Weight Loss Intervention Versus Bariatric Surgery for Adults With Severe and Complex Obesity: the LightBAR Ran
NA · St Richard's Hospital · Carsten Dirksen · NCT06309238 SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Phase N/A · Massive Bio, Inc. · NCT03452774 A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular
Phase 1 · Pfizer · NCT03460977 Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Phase 1 · TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) · NCT06343402 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · National Cancer Institute (NCI) · NCT05256225 An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07517263 A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Al
Phase 3 · Bristol-Myers Squibb · NCT07011745 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 Change 4 Better (C4B)
NA · Yale University · NCT06963931 Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With En
Phase 3 · Genmab · NCT07166094 Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participa
Phase 3 · Amgen · NCT06252649 Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
Phase 1 · OncoTherapy Science, Inc. · NCT02926690 Physiological Versus Right Ventricular Outcome Trial Evaluated for Bradycardia Treatment Upgrades
NA · St. Richard's Hospital - University Hospitals Sussex · Imperial College London · NCT06052475 Genomic Profiling in Cancer Patients
Phase N/A · Memorial Sloan Kettering Cancer Center · NCT01775072 "Physiological vs Right Ventricular Pacing Outcome Trial Evaluated for bradyCardia Treatment" (PROTECT-HF)
NA · St Richard's Hospital · Imperial College London · NCT05815745 Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
Phase 2 · Memorial Sloan Kettering Cancer Center · NCT04084730 Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance C
Phase 3 · National Cancer Institute (NCI) · NCT07061977 A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NA · NRG Oncology · NCT04251052 Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Establish
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06813911 Study of ALTO-300 in MDD
Phase 2 · Alto Neuroscience · NCT05922878 Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Phase 3 · NRG Oncology · NCT06580314 Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After
Phase 3 · Alliance for Clinical Trials in Oncology · NCT05812807 A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals
Phase N/A · Nuvance Health · NCT03250078 MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Stryker Instruments · NCT03072927 A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
Phase 2 · St Richard's Hospital · Pfizer · NCT06991257 A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Partic
Phase 2 · AbbVie · NCT06890338 A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Phase 3 · St. Richard's Hospital_Cardiology · Novo Nordisk A/S · NCT07567001 Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Phase N/A · SWOG Cancer Research Network · NCT04871542

Look up another city

Look up another condition